These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21917422)

  • 21. Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
    Roux C; Binkley N; Boonen S; Kiel DP; Ralston SH; Reginster JY; Pong A; Rosenberg E; Santora A;
    Calcif Tissue Int; 2014 Feb; 94(2):153-7. PubMed ID: 23912950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of ibandronate and eldecalcitol in postmenopausal Japanese women with osteoporosis.
    Takada J; Wada H; Iba K; Sasaki K; Dohke T; Kanaya K; Yoshizaki T; Yamashita T
    J Orthop Surg (Hong Kong); 2016 Dec; 24(3):362-366. PubMed ID: 28031507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of nutrition in the prevention and treatment of osteoporosis].
    Tanaka K; Kishimoto M; Kuwabara A; Ogawa Y; Kido S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():587-90. PubMed ID: 18161171
    [No Abstract]   [Full Text] [Related]  

  • 24. Increase in bone mass after correction of vitamin D insufficiency in bisphosphonate-treated patients.
    Geller JL; Hu B; Reed S; Mirocha J; Adams JS
    Endocr Pract; 2008 Apr; 14(3):293-7. PubMed ID: 18463035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
    Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
    Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical study on combination of multiple regimens in treatment of osteoporosis in perimenopause and postmenopausal women].
    Guan YT; Cai LL; Ding HX; Chen GD; Hu Y
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):571-4. PubMed ID: 21029610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Research of the Application of Bone Turnover Markers in Monitoring the Short-Term Therapeutic Efficacy of Vitamin D in Postmenopausal Osteoporotic women in Harbin, China.
    Zhang Y; Wang Y
    J Nutr Health Aging; 2020; 24(5):485-493. PubMed ID: 32346686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women.
    Chung YE; Lee SH; Lee SY; Kim SY; Kim HH; Mirza FS; Lee SK; Lorenzo JA; Kim GS; Koh JM
    Osteoporos Int; 2012 Apr; 23(4):1235-43. PubMed ID: 21660558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).
    Schafer AL; Sellmeyer DE; Schwartz AV; Rosen CJ; Vittinghoff E; Palermo L; Bilezikian JP; Shoback DM; Black DM
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1982-9. PubMed ID: 21994958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The increase in bone mineral density by bisphosphonate with active vitamin D analog is associated with the serum calcium level within the reference interval in postmenopausal osteoporosis.
    Kinoshita M; Ishijima M; Kaneko H; Liu L; Nagao M; Sadatsuki R; Hada S; Arita H; Aoki T; Yamanaka M; Nojiri H; Sakamoto Y; Tokita A; Kaneko K
    Mod Rheumatol; 2019 Jan; 29(1):157-164. PubMed ID: 29451049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12-month randomized controlled study.
    Flodin L; Sääf M; Cederholm T; Al-Ani AN; Ackermann PW; Samnegård E; Dalen N; Hedström M
    Clin Interv Aging; 2014; 9():1043-50. PubMed ID: 25045257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
    Naylor KE; Bradburn M; Paggiosi MA; Gossiel F; Peel NFA; McCloskey EV; Walsh JS; Eastell R
    Osteoporos Int; 2018 Jun; 29(6):1407-1417. PubMed ID: 29525970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women.
    Jensen C; Holloway L; Block G; Spiller G; Gildengorin G; Gunderson E; Butterfield G; Marcus R
    Am J Clin Nutr; 2002 Jun; 75(6):1114-20. PubMed ID: 12036821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate.
    Catalano A; Morabito N; Di Stefano A; Morini E; Basile G; Faraci B; Loddo S; Ientile R; Lasco A
    J Endocrinol Invest; 2015 Aug; 38(8):859-63. PubMed ID: 25952299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis.
    Bunout D; Barrera G; Leiva L; Gattas V; de la Maza MP; Haschke F; Steenhout P; Klassen P; Hager C; Offord E; Hirsch S
    J Am Coll Nutr; 2006 Jun; 25(3):170-7. PubMed ID: 16766774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone and nutrition in elderly women: protein, energy, and calcium as main determinants of bone mineral density.
    Ilich JZ; Brownbill RA; Tamborini L
    Eur J Clin Nutr; 2003 Apr; 57(4):554-65. PubMed ID: 12700617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass.
    Downs RW; Moffett AM; Ghosh A; Cox DA; Dowsett SA; Harper K
    Osteoporos Int; 2010 Jul; 21(7):1215-26. PubMed ID: 19798460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.